Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 4CNS 2Breast 2Other solid neoplasm 1Lymphoid 1Head & Neck 1Genitourinary 1Endocrine 1

Conditions

Breast Neoplasms 2Anxiety Disorders 1Amenorrhea 1

Interventions

Trastuzumab 696Paclitaxel 679Cyclophosphamide 634Docetaxel 554Capecitabine 468Letrozole 407Carboplatin 393Fulvestrant 379Doxorubicin 330Tamoxifen 288pembrolizumab 272Anastrozole 252Epirubicin 249exemestane 238pertuzumab 229Bevacizumab 214Radiotherapy 213Gemcitabine 211Vinorelbine 188palbociclib 183Lapatinib 175130-nm albumin-bound paclitaxel 168Albumin-Bound Paclitaxel 156Exercise 147Magnetic Resonance Spectroscopy 145eribulin 144Taxes 134Fluorouracil 131Everolimus 118Cisplatin 118

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Postoperative Period × Breast × Clear all
NCT05360407 2022-05-04

The Effect of Mobile Application-based Information About Before and After Surgery

Suleyman Demirel University

Phase NA Completed
82 enrolled
Breast

Anxiety Disorders, Breast Neoplasms

NCT01503905 2016-05-24

Neoadjuvant Chemotherapy for Operable Premenopausal Breast Cancer Patients

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase NA Unknown
600 enrolled
Breast

Amenorrhea, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡